Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
Clinical trial NCT01543204 · TERMINATED
Trial details
- NCT number
- NCT01543204
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2015-05-29
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.